- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Nirvan Pharmaceuticals Private Limited covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (68), financial health (15), director (45) and company-foundation signals.
- Operating for 30+ years.
- Company status is Active as per MCA.
- Last balance sheet filed for Mar 2023 - filings look overdue.
- Loss-making in FY 2022.
- Negative net worth - capital eroded by losses.
- 3 directors on the board.
- Director SUNIL YADAV has DIN status "Disqualified by RoC u/s 164(2)".
About Nirvan Pharmaceuticals Private Limited
Nirvan Pharmaceuticals Private Limited is an MCA-registered Indian company: a Private Limited Indian Non-Government Company (CIN U33112DL1996PTC076859). Business overview includes Pharma (Drug Formulation & Development), incorporated on March 07, 1996 (30+ years old), headquartered in Delhi, Delhi, India. The company is currently Active with Active Compliant compliance status.
- Location H - 4/9, Model Town,, Delhi, Delhi - 110009
Financial Performance of Nirvan Pharmaceuticals Private Limited
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Nirvan Pharmaceuticals Private Limited (3)
Charges of Nirvan Pharmaceuticals Private Limited
| Lender | Amount | Status |
|---|---|---|
|
Others
Creation Date: 09 Feb 2018 |
19.36 cr | Open |
|
Bajaj Finance Limited
Creation Date: 02 Jul 2015 |
10.00 cr | Open |
|
Bajaj Finance Limited
Creation Date: 31 Dec 2014 |
18.00 cr | Open |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
